Related Experiment Video
Updated: Jun 21, 2026

13:19
Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013
19.4K
Smart Screening in Prostate Cancer: What We Have Learned So Far from PROBASE
Rouvier Al-Monajjed1, Agne Krilaviciute2, Peter Albers1
1Department of Urology, University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Düsseldorf, Germany; Division of Personalized Early Detection of Prostate Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
European Urology Focus
|April 28, 2026
Abstract
None:
Smart prostate cancer screening means screening better: risk stratification, prostate-specific antigen confirmation, expert magnetic resonance imaging, and prostate-specific antigen density-guided biopsy reduce harm without compromising detection of significant disease.

